Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 2 7Phase 3 2Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Periampullary Cancer 1Pancreatic Ductal Adenocarcinoma 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Pancreaticoduodenectomy × Clear all
NCT05843877 2026-01-30

XandTX

Technische Universität Dresden

Phase 3 Recruiting
32 enrolled
Gastrointestinal

Periampullary Cancer

NCT03317886 2017-10-24

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

Wakayama Medical University

Phase 3 Unknown
354 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡